Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
Neuro-inflammatory processes that contribute to development of Alzheimer’s are evident early in the latent prodromal phase and worsen during the course of the disease. Despite substantial mechanistic and clinical evidence of inflammation, therapeutic approaches targeting inflammation have failed to alter the course of the disease. Disparate results from epidemiological and clinical trials targeting inflammation, highlight the complexity of the inflammatory process. Herein we review the dynamics of the inflammatory process across aging, midlife endocrine transitions, and the APOEε4 genotype and their contribution to progression of Alzheimer’s disease (AD). We discuss the chronic inflammatory processes that are activated during midlife chronological and endocrine aging, which ultimately limit the clearance capacity of microglia and lead to immune senescence. Aging, menopause, and APOEε4 combine the three hits of a compromised bioenergetic system of menopause with the chronic low grade innate inflammation of aging with the APOEε4 dyslipidemia and adaptive immune response. The inflammatory immune response is the unifying factor that bridges across each of the risk factors for AD. Immune system regulators that are specific to stage of disease and inflammatory phenotype would provide a therapeutic strategy to disconnect the bridge that drives disease. Outcomes of this analysis provide plausible mechanisms underlying failed clinical trials of anti-inflammatory agents in Alzheimer...
;import{g as i,s as o,r as s,e as a,a as u,h as l,b as c,i as h,t as f,c as d,d as p,f as m,j as g,k as y,l as b,K as v,_ as w,S as E,m as _,o as C,w as M,n as S,p as O,q as B,u as D,v as I,x as T,y as x,z as R,A as N,G as k,J as F,B as L,C as P,X as U,D as j,E as q,F as z,H as $,I as V,L as H,M as W,N as G,O as K,P as Z,Q as Y,R as J,T as X,U as Q,V as AA,W as eA,Y as tA,Z as rA,$ as nA,a0 as iA,a1 as oA,a2 as sA,a3 as aA,a4 as uA,a5 as lA,a6 as cA,a7 as hA,a8 as fA,a9 as dA,aa as pA,ab as mA,ac as gA,ad as yA,ae as bA,af as vA,ag as wA,ah as EA,ai as _A,aj as CA,ak as MA,al as SA,am as OA}fr
saved by
related reading
- Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
- Frontiers | Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportfrontiersin.org
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- The amyloid hypothesis in Alzheimer disease: new insights from new therapeuticsnature.com
- APOE2 is associated with longevity independent of Alzheimer’s diseasencbi.nlm.nih.gov
- Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
- Frontiers | The Role of NK Cells and Innate Lymphoid Cells in Brain Cancerfrontiersin.org
- Frontiers | Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brainfrontiersin.org
- Frontiers | The Defensive Activation Theory: REM Sleep as a Mechanism to Prevent Takeover of the Visual Cortexfrontiersin.org
- A body–brain circuit that regulates body inflammatory responsesnature.com
- APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease | Nature Medicinenature.com
- Frontiers | Decoding EEG Brain Activity for Multi-Modal Natural Language Processingfrontiersin.org